Guardant Health, Inc. — Director's Dealing 2023

Nov 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Guardant Health, Inc. (GH)
CIK: 0001576280
Period of Report: 2023-11-15

Reporting Person: POTTER MYRTLE S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-15	COMMON STOCK	M	68	—	Acquired	7240	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-15	RESTRICTED STOCK UNITS	$0	M	68	Disposed		COMMON STOCK (68)	Direct

Footnotes

F1: The restricted stock unit vests as to 25% of the shares subject to such award on October 15, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of October 15, 2022, during the three-year period thereafter.

F2: Not applicable for Restricted Stock Units.